OUTSOURCE
BRCA1 & BRCA2 MUTATION DRUG PROFILING PANEL (N195)
Also Known As:
BRCA1 & BRCA2 MUTATION DRUG PROFILING PANEL
About This Test
This assay detects most of the mutations and insertions/deletions in the BRCA gene which is linked to breast/ovarian cancer. Using the Oncomine Knowledge base, this assay predicts the response of drugs such as PARP inhibitors and helps to tailor the therapy. PARP inhibition results in selective killing of cancer cells which have lost BRCA1 or BRCA2 function.
Test Parameters (1)
- BRCA1 & BRCA2 MUTATION DRUG PROFILING PANEL
Home Collection
✗ Not Available
Reports Available In
1 Day
Frequently Asked Questions
Outsourced test are being done from Dr. Lal Path Lab. Charges and reporting time is same as of Dr. Lal Path Labs.
No special preparation required
This test is important for tailoring cancer treatment based on BRCA mutation profile to maximize effectiveness and minimize unnecessary therapy.
TAT Policy
The Turnaround Time (TAT) depends on the following factors:
- Registration date and time
- Type of scan or test
- Scan time or sample collection time
In uncommon circumstances, TAT may be delayed due to test complexity or reasons beyond our control. You will be informed of the estimated TAT at the time of registration.
